United States Mobile Cardiac Telemetry (MCAT) Market

United States Mobile Cardiac Telemetry (MCAT) Market Size & Forecast:

• United States Mobile Cardiac Telemetry (MCAT) Market Size 2025: USD 399.98 Million
• United States Mobile Cardiac Telemetry (MCAT) Market Size 2033: USD 946.65 Million 
• United States Mobile Cardiac Telemetry (MCAT) Market CAGR: 11.40%
• United States Mobile Cardiac Telemetry (MCAT) Market Segments:By Device Type (Lead-Based MCAT Devices, Patch-Based MCAT Devices), By End User (Hospitals, Cardiology Clinics, Homecare Settings). 

To learn more about this report,  Download Free Sample Report

United States Mobile Cardiac Telemetry (MCAT) Market Summary: 

The United States Mobile Cardiac Telemetry (MCAT) market size is estimated at USD 399.98 million in 2025 and is anticipated to reach USD 946.65 million by 2033, growing at a CAGR of 11.40% from 2026 to 2033. The MCAT market in the United States is experiencing continuous growth because of rising cardiovascular disease rates and a greater need for instant patient monitoring. The development of advanced wearable technology together with better wireless systems enables healthcare professionals to deliver remote cardiac treatment with increased accessibility and dependable performance. The adoption of MCAT solutions by healthcare providers enables them to improve their diagnosis capabilities while decreasing the number of hospital visits. The market for MCAT solutions in the United States continues to grow because of patient awareness and because reimbursement policies support this technology as a vital element of contemporary patient-centred cardiac treatment.

Key Market Trends & Insights: 

• Wearable MCAT devices which enable continuous monitoring outside of hospitals have seen increased usage due to growing heart health awareness and advancements in technology. Patients now have more control over their cardiac health.

• Healthcare providers are using MCAT solutions to identify arrhythmias and other heart conditions during their initial stages. The trend results in fewer emergency medical procedures while enhancing the long-term health results of patients.

• MCAT devices now establish connections with telehealth systems because they enable patients to share their medical data with cardiologists. This system improves the management of patients who need remote treatment while decreasing the number of times patients need to visit hospitals.

• MCAT systems use advanced analytics and artificial intelligence to provide physicians with rapid cardiac data analysis. The trend results in better decision-making processes and the creation of individualised treatment strategies.

• Patients now choose to monitor their health from home because it provides them with safer and more convenient options. MCAT solutions have developed to meet this need by providing patients with the comfort and medical help which they need without having to stay in hospitals.

• MCAT devices undergo continuous innovation, which makes them smaller and lighter and easier to use for users. The system enables patients to follow their medical treatments and receive monitoring throughout a long period without experiencing any difficulties.

United States Mobile Cardiac Telemetry (MCAT) Market Segmentation

By Device Type

• Lead-Based MCAT Devices: The medical field continues to use lead-based MCAT devices because these instruments provide accurate measurements of continuous heart rate monitoring. The devices use multi-lead data to create detailed cardiac measurements which help medical professionals treat complicated heart conditions. The medical facilities use these instruments to obtain exact medical results which modern technological advancements make more comfortable and usable for patients.

• Patch-Based MCAT Devices: People prefer patch-based MCAT devices because these systems provide simple operation and invisible wearability. The equipment provides wireless mobility for patients who need to continue their regular activities without interruptions. The medical field increasingly uses these devices for home healthcare and outpatient treatment because they deliver uninterrupted patient monitoring, which helps doctors make better medical decisions.

To learn more about this report,  Download Free Sample Report

By End User

• Hospitals: MCAT devices serve as essential tools for hospitals which use them in their cardiology departments to provide continuous patient monitoring. The solutions provide assistance to healthcare professionals who work with high-risk patients by assisting them in all aspects of their emergency care needs. Hospitals use data analytics from MCAT devices to enhance their clinical decision-making processes and deliver better patient treatment results.

• Cardiology Clinics: MCAT devices have become standard equipment for cardiology clinics which use them to monitor patients who experience persistent or temporary heart problems. The devices enable specialists to observe their patients' heart functions from a distance, which helps them detect issues earlier while developing customized treatment strategies. The clinics achieve better patient results and enhanced operational performance through their efficient monitoring processes.

• Homecare Settings: Patients choose to use MCAT devices at home because they want to experience healthcare comfort while maintaining contact with their medical team. Home care patients can receive continuous medical supervision through wearable and patch-based solutions which eliminate their need for hospital attendance. Patients receive comforting support from their healthcare providers who use trustworthy real-time information to handle their medical care.

Country Insights

The United States holds the top position in the North American Mobile Cardiac Telemetry (MCAT) market because of increasing cardiovascular disease rates and growing knowledge about early diagnosis methods and remote patient monitoring. The MCAT solutions market receives support from advanced healthcare facilities which have become common due to people using wearable devices and telehealth services. Medical facilities and cardiology practices and home health care providers use these devices to monitor patients' heart conditions continuously throughout the day, which leads to better health results and fewer patients needing to return to hospitals. Patients can now use remote monitoring because of technological progress which includes patch-based and wireless MCAT devices. 

The market experiences expansion because reimbursement policies support services while the focus on preventive healthcare grows. The U.S. market receives advantages through major research and development funding which results in better accuracy and comfort and usability improvements for MCAT devices. The United States establishes standards for both advanced cardiac treatment and the use of remote patient monitoring technology.

Recent Development News

Remote Cardiac Monitoring Market Set to Grow Rapidly: The U.S. contributes significantly to a booming remote cardiac monitoring market, driven by advanced wearable sensors, telehealth growth, and rising cardiac disease prevalence. 

Ambulatory ECG Monitoring Market Expands in North America: The ambulatory ECG market — closely tied to MCAT and continuous cardiac monitoring — is projected to nearly double by 2033. 

Key United States Mobile Cardiac Telemetry (MCAT) Company Insights

The top US mobile cardiac telemetry MCAT market companies work to develop new products which will enhance their testing precision and make their services more convenient for patients. The company develops wearable devices which let users monitor their heart rhythms in real time while maintaining comfortable and dependable performance. The company uses strategic partnerships to extend its market coverage by connecting with hospitals and cardiology clinics and telehealth providers. The companies are developing their diagnostic systems by implementing data analytics together with artificial intelligence technology. The companies improve their market position and increase adoption of new MCAT technologies through ongoing research and development together with supportive reimbursement policies and rising patient understanding.

Company List

• BioTelemetry Inc.
• iRhythm Technologies Inc.
• Preventice Solutions Inc.
• ScottCare Corporation
• Medicomp Inc.
• Cardiac Insight Inc.
• Medtronic PLC
• Philips Healthcare
• GE HealthCare Technologies Inc.
• Hillrom Holdings Inc.
• Bardy Diagnostics Inc.
• LifeWatch AG
• VitalConnect Inc.
• Qardio Inc.
• AliveCor Inc.

United States Mobile Cardiac Telemetry (MCAT) Market Report Segmentation

By Device Type

• Lead-Based MCAT Devices
• Patch-Based MCAT Devices

By End User

• Hospitals
• Cardiology Clinics
• Homecare Settings